SEARCH

SEARCH BY CITATION

References

  • 1
    Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54/2:254-260.
  • 2
    Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012;18/3:363-374.
  • 3
    Mattila I, Seppänen-Laakso T, Suortti T, et al. Application of lipidomics and metabolomics to the study of adipose tissue. Methods Mol Biol 2008;456:123-130.
  • 4
    Felber JP, Ferrannini E, Golay A, et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 1987;36/11:1341-1350.
  • 5
    Layden BT, Yalamanchi SK, Wolever TM, et al. Negative association of acetate with visceral adipose tissue and insulin levels. Diabet Metab Syndr Obes 2012;5:49-55.
  • 6
    Lin HV, Frassetto A, Kowalik EJ, Jr., et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012;7/4:e35240.
  • 7
    Kim JY, Park JY, Kim OY, et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 2010;9/9:4368-4375.
  • 8
    Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9/4:311-326.
  • 9
    Huffman KM, Shah SH, Stevens RD, et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabet Care 2009;32/9:1678-1683.
  • 10
    Mihalik SJ, Goodpaster BH, Kelley DE, et al. DeLany Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) 2010;18/9:1695-1700.
  • 11
    Cheng S, Rhee EP, Larson MG, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012;125/18:2222-2231.
  • 12
    Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17/4:448-453.
  • 13
    Hanzu FA, Palomo M, Kalko SG, et al. Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses. J Thromb Haemost 2011;9/6:1236-1245.
  • 14
    Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145/5:2273-2282.
  • 15
    Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964;239:375-380.
  • 16
    Papazoglu M, Fiehn O. Metabolite identification in blood plasma using CG/MS and the agilent fiehn GC/MS metabolomics RTL library. Agilent Application Note 2009.
  • 17
    Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003;100:9440-9445.
  • 18
    Brosnan JT. Interorgan amino acid transport and its regulation. J Nutr 2003;133/6(Suppl 1):2068S-2072S.
  • 19
    Guarino MP, Macedo MP. Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol 2006;147/8:959-965.
  • 20
    Guarino MP, Afonso RA, Raimundo N, et al. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am J Physiol Gastrointest Liver Physiol 2003;284/4:G588-G594.
  • 21
    Herman MA, She P, Peroni OD, et al. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 2010;285/15:11348-11356.
  • 22
    Pietilainen KH, Naukkarinen J, Rissanen A, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008;5/3:e51.
  • 23
    Mihalik SJ, Michaliszyn SF, de las HJ, et al. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabet Care 2012;35/3:605-611.
  • 24
    Perez-Perez R, Garcia-Santos E, Ortega-Delgado FJ, et al. Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue. J Proteom 2012;75/3:783-795.
  • 25
    Anderson SR, Gilge DA, Steiber AL, et al. Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice. Metabolism 2008;57/3:347-354.
  • 26
    Patterson BW, Horowitz JF, Wu G, et al. Regional muscle and adipose tissue amino acid metabolism in lean and obese women. Am J Physiol Endocrinol Metab 2002;282/4:E931-E936.
  • 27
    Tischler M, Goldberg A. Leucine degradation and release of glutamine and alanine by adipose tissue. J Biol Chem 1980;255/17:8074-8081.
  • 28
    Frayn KN, Khan K, Coppack SW, et al. Amino acid metabolism in human subcutaneous adipose tissue in vivo. Clin Sci (Lond) 1991;80/5:471-474.
  • 29
    Felig P, Wahren J, Hendler R, et al. Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest 1974;53/2:582-590.
  • 30
    Takayuki T, Yuko I, Toru M, et al. Plasma amino acid profile is altered by visceral fat accumulation and is a predictor of visceral obesity in humans. From Nature Proceedings Available at: http://hdl.handle.net/10101/npre.2011.5560.1 (2011).
  • 31
    Rossell R, Gomis R, Casamitjana R, et al. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab 1983;56:608-611.
  • 32
    Felig P, Marliss E, Cahill GF, Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969;281/15:811-816.
  • 33
    Nilsson M, Holst JJ, Bjorck IM. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 2007;85/4:996-1004.
  • 34
    Patti ME, Brambilla E, Luzi L, et al. Bidirectional modulation of insulin action by amino acids. J Clin Invest 1998;101/7:1519-1529.
  • 35
    Tremblay F, Lavigne C, Jacques H, et al. Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr 2007;27:293-310.
  • 36
    Caballero B, Wurtman RJ. Differential effects of insulin resistance on leucine and glucose kinetics in obesity. Metabolism 1991;40/1:51-58.
  • 37
    Luzi L, Castellino P, DeFronzo RA. Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol 1996;270/2(Part 1):E273-E281.
  • 38
    Zhang Y, Guo K, LeBlanc RE, et al. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007;56/6:1647-1654.
  • 39
    Shah SH, Crosslin DR, Haynes CS, et al. LP. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 2012;55/2:321-330.